Skip to main content

Pfizer’s stock down 8% as 2024 profit and revenue guidance falls short of expectations

Drugmaker expands cost-cutting program as it wraps up Seagen acquisition.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.